首页> 外国专利> THIOPHOSPHI(O)NIC ACID DERIVATIVES AND THEIR USE AS AGONISTS OR ANTAGONISTS FOR METABOTROPIC GLUTAMATE RECEPTORS

THIOPHOSPHI(O)NIC ACID DERIVATIVES AND THEIR USE AS AGONISTS OR ANTAGONISTS FOR METABOTROPIC GLUTAMATE RECEPTORS

机译:硫代膦酸衍生物及其作为代谢型谷氨酸受体的激动剂或拮抗剂

摘要

The invention relates to thiophosphi(o)nic acid derivatives having formula (I) wherein. M is a [C(R3,R4)]n1 - C(E,COOR1, N(H, Z)) group, or an optionally substituted Ar-CH(COOR1, N(H, Z)) group (Ar designating an aryl or an heteroaryl group), or an a, ß cyclic aminoacid group such as, formula (II) or a ß, ?-cyclic aminoacid group such as, formula (III). R1 is H or R, R being an hydroxy or a carboxy protecting group, such as C1-C3 alkyl, Ar (being aryl or heteroaryl),. Z is H or an amino protecting group R', such as C1-C3 alkyl, C1-C3 acyl, Boc, Fmoc, COOR, benzyl oxycarbonyl, benzyl or benzyl substituted such as defined with respect to Ar;. E is H or a C1-C3 alkyl, aryl, an hydrophobic group such as (CH2)n1 -alkyl, (CH2)n1-aryl (or heteroaryl), such as a benzyl group, or a xanthyl, alkyl xanthyl or alkyl thioxanthyl group, or - (CH2)n1-cycloalkyl, -(CH2)n-(CH2-Ar)2, a chromanyl group, particularly 4-methyl chromanyle, indanyle, tetrahydro naphtyl, particularly methyl-tetrahydronaphtyl; or M is OM', wherein M' is as above defined for M;. R2 is selected in the group comprising: D-CH(R6)- C-(R7, R8) - (R11,R12)CH- C(R9.R10) - D - CH(OH) - D- [C(R13, R14)]n3 - C[(R15, R16, R17)]n4 - D-CH2 - (R18)CH = C(R19) - D-(M1)n6-CO- D-C(R,R')-O- D-O-, formula (IV), PO(OH)2-CH2 or (PO(OH)2-CH2), (COOH-CH2)-CH2- with - D = H, OH, OR, (CH2)n2OH, (CH2)n1OR, COOH, COOR, (CH2)n2COOH, (CH2)n1C00R, SR, S(OR), SO2R, NO2, heteroaryl, C1-C3 alkyl, cycloalkyl, heterocycloalkyl, (CH2)n2-alkyl, (COOH, NH2)-(CH2)u1-cyclopropyl-(CH2)u2-, CO-NH-alkyl, Ar, (CH2)n2-Ar, CO-NH-Ar, R being as above defined and Ar being an optionally substituted aryl or heteroaryl group, - R3 to R19, identical or different, being H, OH, OR, (CH2)n2OH, (CH2)n1OR, COOH, COOR, (CH2)n2COOH, (CH2)n1COOR, C1-C3 alkyl, cycloalkyl, (CH2)n1 -alkyl, aryl, (CH2)n1-aryl, halogen, CF3, SO3H, (CH2)X PO3H2, with x = 0, 1 or 2, B(OH)2, formula (V), NO2, SO2NH2, SO2NHR; SR, S(O)R, SO2R, benzyl; one of R11 or R12 being COOR, COOH, (CH2)n2-COOH, (CH2)n2-COOR, PO3H2 the other one being such as defined for R9 and R10; - one Of R15, R16 and R17 is COOH or COOR, the others, identical or different, being such as above defined; - one of R18 and R19 is COOH or COOR, the other being such as
机译:本发明涉及具有式(I)的硫代膦酸(o)酸衍生物,其中。 M为[C(R3,R4)] n1-C(E,COOR1,N(H,Z))基团,或可选取代的Ar-CH(COOR1,N(H,Z))基团(Ar表示芳基或杂芳基),或诸如式(II)之类的α,环状氨基酸基团,或诸如式(III)之类的β,环状氨基酸基团。 R1为H或R,R为羟基或羧基保护基,例如C1-C3烷基,Ar(为芳基或杂芳基)。 Z是H或氨基保护基R',例如C 1 -C 3烷基,C 1 -C 3酰基,Boc,Fmoc,COOR,苄氧羰基,苄基或苄基或如关于Ar所定义的被取代的苄基。 E为H或C 1 -C 3烷基,芳基,诸如(CH 2)n 1-烷基的疏水基团,(CH 2)n 1-芳基(或杂芳基)诸如苄基或黄蒽基,烷基黄蒽基或烷基硫杂蒽基。基团,或-(CH 2)n 1-环烷基,-(CH 2)n-(CH 2 -Ar)2,苯并吡喃基,特别是4-甲基苯并二氢萘基,茚满基,四氢萘基,特别是甲基-四氢萘基。或M为OM′,其中M′如以上对M 1所定义。 R 2选自:D-CH(R6)-C-(R7,R8)-(R11,R12)CH- C(R9.R10)-D- CH(OH)-D- [C(R13 ,R14)] n3-C [(R15,R16,R17)] n4-D-CH2-(R18)CH = C(R19)-D-(M1)n6-CO- DC(R,R')-O -DO-,式(IV),PO(OH)2 -CH 2或(PO(OH)2 -CH 2),(COOH-CH 2)-CH 2-,其中-D = H,OH,OR,(CH 2)n 2 OH, (CH2)n1OR,COOH,COOR,(CH2)n2COOH,(CH2)n1C00R,SR,S(OR),SO2R,NO2,杂芳基,C1-C3烷基,环烷基,杂环烷基,(CH2)n2-烷基,(COOH ,NH 2)-(CH 2)u 1-环丙基-(CH 2)u 2-,CO-NH-烷基,Ar,(CH 2)n 2 -Ar,CO-NH-Ar,R如上定义,且Ar为任选取代的芳基或杂芳基,-R3至R19,相同或不同,为H,OH,OR,(CH2)n2OH,(CH2)n1OR,COOH,COOR,(CH2)n2COOH,(CH2)n1COOR,C1-C3烷基,环烷基,(CH2)n1-烷基,芳基,(CH2)n1-芳基,卤素,CF3,SO3H,(CH2)X PO3H2,其中x = 0、1或2,B(OH)2,式(V),NO2 ,SO2NH2,SO2NHR; SR,S(O)R,SO2R,苄基; R11或R12之一是COOR,COOH,(CH2)n2-COOH,(CH2)n2-COOR,PO3H2,另一个是如R9和R10所定义的; -R15,R16和R17之一是COOH或COOR,其他相同或不同,如上所定义; -R18和R19中的一个是COOH或COOR,另一个是

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号